Jun 30, 2023

Xenon Pharmaceuticals Q2 2023 Earnings Report

EPS
-$0.72
Previous year: -$0.55
+30.9%
Cash and Equivalents
$64.6M
Previous year: $788M
-91.8%
Free Cash Flow
-$35.4M
Previous year: -$17.4M
+103.0%
Total Assets
$685M
Previous year: $807M
-15.2%

Xenon Pharmaceuticals

Xenon Pharmaceuticals